Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + mefloquine for uncomplicated falciparum malaria in Thailand
ACTRN12610000553077Phase 4Not yet recruiting
- Sponsor
- Bureau of Vector Borne Diseases
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate, mefloquine and primaquine in Malaria, sponsored by Bureau of Vector Borne Diseases. Primary endpoint: WHO-classified treatment outcome. Planned start Aug 2010; status: not yet recruiting.
02
Drugs
artesunatemefloquineprimaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12610000553077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000553077.